## **Core Concept**
Muir-Torre syndrome is a rare genetic disorder characterized by the occurrence of **sebaceous neoplasms** (such as sebaceous adenomas, sebaceous epitheliomas, sebaceous carcinomas, and keratoacanthomas) and an increased risk of developing **internal malignancies**, particularly colorectal cancer. This syndrome is considered a subtype of **Lynch syndrome** (hereditary nonpolyposis colorectal cancer or HNPCC).

## **Why the Correct Answer is Right**
The correct answer involves understanding the association of Muir-Torre syndrome with **Lynch syndrome** and its manifestations, including **sebaceous tumors** and **internal malignancies**. Lynch syndrome is caused by mutations in DNA mismatch repair genes, such as *MLH1*, *MSH2*, *MSH6*, and *PMS2*. Muir-Torre syndrome specifically is often linked to mutations in *MSH2* and *MLH1*. The presence of sebaceous neoplasms serves as a cutaneous marker for the syndrome, which alerts clinicians to the potential for associated internal malignancies.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately reflect the characteristics of Muir-Torre syndrome.
- **Option B:** This option is incorrect as it does not specify the correct association with Muir-Torre syndrome.
- **Option C:** Although not directly addressed, any option not aligned with the association of sebaceous neoplasms and internal malignancies, particularly in the context of Lynch syndrome, would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of **sebaceous neoplasms** should prompt consideration of Muir-Torre syndrome and an evaluation for **Lynch syndrome**. Early recognition can lead to screening and preventive measures for associated internal malignancies, particularly **colorectal cancer**. A useful mnemonic or association is that Muir-Torre syndrome is a "cutaneous marker" for Lynch syndrome.

## **Correct Answer:** D.